For an overview of assessment at baseline, 12-week-posttreatment and 6-month follow-up see Table 2.
For an overview of assessment at baseline, post-treatment, 6-and 12-month follow-up see Table 1.
For an overview of assessments at baseline, during the intervention and during follow-up, see Table 1.
Table 2 provides an overview of the timeframe for assessment and the measures that are used.
In this paper, we provide a brief overview on AD scales developed for assessment of cognition, daily function, global impression, behavior, quality of life as well as communication and social interaction, with a focus on their applicability in daily medical practice for monitoring disease progression and therapy effects.
The Intra Class Correlation Coefficient of the total score for AMSTAR was 0.84 (95% confidence interval: 0.65, 0.92), compared with 0.91 (95% confidence interval: 0.82, 0.96) for the Overview Quality Assessment Questionnaire, and 0.86 (95% confidence interval: 0.71, 0.94) for the Sacks' instrument.
While firm evidence is lacking, the ability of these programs to provide protection against unemployment risk – in absence of solidarity funding – is questionable, particularly as these programs are plagued by deficient financial management (for an overview and assessment of these programs in Argentina, Brazil, Colombia, Ecuador, Panama, Peru and Venezuela, see Ferrer and Riddell2012).
For an overview and assessment of that course, see Brownell et al. (2012) and Kloser et al. (2013).
For an overview of the assessments at baseline, in between- and post treatment and follow up assessments see Table 1.
For an overview of the assessments at baseline, in between- and post treatment and follow up assessments see table 1. Participants can withdraw from treatment or from the study at any time.
*T0 = Baseline, T1 = +1,5 month, T2 = 3 months, T3 = 6 months, T4 = 9 months, T5 = 12 months, T6 = 15 months, T7 = 18 months, T8 = 21 months, T9 = 24 months **MAQ: Medication Adherence questionnaire For an overview of the assessments at baseline, in between- and post treatment and follow up assessments see Table 1.
